Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
estrogen nuclear receptor alpha | 8 | 0 | 0 | 8 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Bile salt export pump | 0 | 8 | 0 | 8 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
AR protein | 8 | 0 | 0 | 8 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
caspase-3 | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
Caspase-7 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 6 | 0 | 0 | 6 |
geminin | 6 | 0 | 0 | 6 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Insulin receptor | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 4 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 5 |
pregnane X receptor | 1 | 0 | 0 | 1 |
progesterone receptor | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
IDH1 | 4 | 0 | 0 | 4 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
ORF73 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Beta-lactamase TEM | 0 | 1 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Efflux transporter | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 3 |
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
Cytochrome P450 71B1 | 0 | 1 | 0 | 2 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
2-dehydro-3-deoxyphosphooctonate aldolase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
GLS protein | 1 | 0 | 0 | 1 |
TDP1 protein | 2 | 0 | 0 | 2 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
G | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 2 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 1 | 2 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Androgen receptor | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 2 | 2 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
Caspase-1 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |